Childhood obesity is influenced by more than diet and weight, with sleep, screen time, physical activity and daily routines shaping children’s long-term metabolic health.
A Tulsa pediatrician explains the growing concern over childhood obesity, what parents should know about GLP-1 medications and the importance of nutrition, exercise and healthy habits.
Novo Nordisk’s STEP Young trial explores semaglutide for childhood obesity.
As national attention increases on children’s physical activity, fitness expert Amy Burton highlights an overlooked PE .
New research to be presented at the European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12–15 May) shows that living with obesity in childhood is associated with lower future levels of education .
While childhood obesity has become more common in recent years, this is a condition that is about more than just weight.
New research challenges the decades-old idea that children experience an “adiposity rebound” when their BMI begins rising around age 6.
Although the number of US children under age 12 with obesity being prescribed the weight loss drugs Saxenda, Wegovy, and Zepbound remains low, the number is 310 times higher in June 2026 than it was .
Data highlights The STEP Young phase 3 trial met its primary endpoint, demonstrating greater body mass index (BMI) reduction in children aged 6 to under 12 treated with once-weekly subcutaneous .
Scientists studying Maria Branyas, who lived to 117, found signs of extreme aging alongside biological features linked to healthy longevity.
Childhood obesity is a serious health problem that has adverse and long-lasting consequences for individuals, families, and communities.